pharma is the sole category represented across all 1 tracked stories. Elizabeth Brannen is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Stris & Maher LLP appears in 1 tracked Biotech story from August 24, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Stris & Maher LLP
pharma is the sole category represented across all 1 tracked stories. Elizabeth Brannen is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Stris & Maher LLP appears in 1 tracked Biotech story from August 24, 2026. The tracked stories average 2 original sources each.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 6 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Stris & Maher LLP. Shared-story counts are live from our verified record — not editorial picks.
Stris & Maher's four-partner team adds Hatch-Waxman, PTAB, and biological sciences depth, giving biopharma companies expanded counsel for patent disputes across branded and generic markets.